Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: A retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma

Cancer

Volumn 116, Issue 2, 2010, Pages 393-399

  Iwamoto, Shozo ^a   Yamaguchi, Taizo ^a   Hongo, Osamu ^a   Iwamoto, Hideki ^b   Sanefuji, Hayato ^c  

^a Iwamoto Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kitakyushu General Hospital   (Japan)

Author keywords

Arterial vascularization; Chemoembolization; Computed tomographic angiography; Portal vein embolization; Treatment of hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ANGIOGRAPHIC SUBSEGMENTECTOMY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PORTAL VEIN; PRIORITY JOURNAL; RECURRENCE RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 75649144779     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24678     Document Type: Article

References (23)

1. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology. 1986;6:729-738.
2. Okuda K, Takayasu K. Primary malignant tumors of the liver. In: Okuda K, Takayasu K, eds. Hepatobiliary Diseases. Oxford, United Kingdom: Blackwell Science; 2001:343-389.
3. Bruix J, Branco F, Ayuso C. Hepatocellular carcinoma. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins;2006:1253-1263.
4. Johnson P. Malignant tumors of the liver. In: Bacon BR, O'Grady JG, Di Bisceglie AM, Lake JR, eds. Comprehensive Clinical Hepatology. 2nd ed. Philadelphia, Pa: Elsevier Mosby; 2006:453-485.
5. Hasegawa K, Kokudo N, Makuuchi M. Surgical management of hepatocellular carcinoma. Liver resection and liver transplantation. Saudi Med J. 2007;28:1171-1179.
6. Poon RT, Fan ST, Lo CM, et al. Long term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235:373-382.
7. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:539-545.
8. Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008;48:819-827.
9. Castroagudin JF, Morina E, Busmanante M, et al. Orthotopic liver transplantation for hepatocellular carcinoma: a 13-year single-center experience. Transplant Proc. 2008;40: 2075-2077.
10. Ikai I, Ari S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676-691.
11. Matuzaki R, Omata M. Treatment of hepatocellular carcinoma. Indian Gastroentrol. 2008;27:113-122.
12. Hasegawa K, Makuuti M, Takayama T, et al. Surgical resection vs percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594.
13. Zavaglia C, Corso R, Rampoldi A, et al. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure? Eur J Gastroenterol Hepatol. 2008;20:196-201.
14. Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
15. Uchida H, Ohishi H, Matsuo N, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:140-145.
16. Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegment transcatheter arterial embolization. Radiology. 1993;188:79-83.
17. Nakamura H, Hashimoto T, Oi H, et al. Treatment of hepatocellular carcinoma by segmental hepatic artery injection of Adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol. 1990;31:347-349.
18. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. Am J Roentegenol. 2001;176: 681-688.
19. Nakamura H, Hashimoto T, Oi H, Sawada S. Iodized oil in the portal vein after arterial embolization. Radiology. 1998;167:415-417.
20. Miyayama S, Matsui O, Yamashiro M, et al. Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol. 2007; 18:365-376.
21. Iwamoto S, Sanefuji H, Okuda K. Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer. 2003;97:1051-1056.
22. Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24:4293-4300.
23. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-442.